title: Containing hepatitis C.
abstract: Screening of donated blood has eliminated a major transmission route for hepatitis C, the accuracy of diagnostic tests has improved, and longer regimens of interferon have improved therapeutic response. Nevertheless, millions are infected, and other transmission routes remain open. Treatment is often unsuccessful, but it may offer the only check to slow destruction of the liver.
authors.affiliation: University of Texas Southwestern Medical Center at Dallas, USA.
authors.forename: W C
authors.initials: WC
authors.lastname: Maddrey
mesh_terms: D000208:Acute Disease; D000328:Adult; D000465:Algorithms; D000998:Antiviral Agents / Q000008:administration & dosage; D001706:Biopsy; D002908:Chronic Disease; D005260:Female; D006526:Hepatitis C / Q000175:diagnosis* / Q000628:therapy / Q000635:transmission; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage; D008099:Liver / Q000473:pathology; D008111:Liver Function Tests; D011379:Prognosis; D011994:Recombinant Proteins
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins